Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.478
Filtrar
2.
J Dairy Sci ; 106(7): 4599-4607, 2023 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-37225581

RESUMEN

This study aimed to evaluate the effects of triglycerides containing medium-chain fatty acids (MCT) and tributyrin (TB) supplementation in a milk replacer (MR) on growth performance, plasma metabolites, and hormone concentrations in dairy calves. Sixty-three Holstein heifer calves (body weight at 8 d of age, 41.1 ± 2.91 kg; mean ± SD) were randomly assigned to 1 of 4 experimental MR (28% crude protein and 18% fat): (1) containing 3.2% C8:0 and 2.8% C10:0 (in fat basis) without TB supplementation (CONT; n = 15), (2) containing 6.7% C8:0 and 6.4% C10:0 without TB supplementation (MCT; n = 16), (3) containing 3.2% C8:0 and 2.8% C10:0 with 0.6% (dry matter basis) TB supplementation (CONT+TB; n = 16), (4) containing 6.7% C8:0 and 6.4% C10:0 with 0.6% TB supplementation (MCT+TB; n = 16). The MR were offered at 600 g/d (powder basis) from 8 to 14 d, up to 1,300 g/d from 15 to 21 d, 1,400 g/d from 22 to 49 d, down to 700 g/d from 50 to 56 d, 600 g/d from 57 to 63 d, and weaned at 64 d of age. All calves were fed calf starter, chopped hay, and water ad libitum. The data were analyzed using a 2-way ANOVA via the fit model procedure of JMP Pro 16 (SAS Institute Inc.). Medium-chain fatty acid supplementation did not affect the total dry matter intake. However, calves that were fed MCT had greater feed efficiency (gain/feed) before weaning (0.74 ± 0.098 vs. 0.71 ± 0.010 kg/kg) compared with non-MCT calves. The MCT calves also had a lower incidence of diarrhea compared with non-MCT calves during 23 to 49 d of age and the weaning period (50 to 63 d of age; 9.2% vs. 18.5% and 10.5% vs. 17.2%, respectively). Calves fed with TB had a greater total dry matter intake during postweaning (3,465 vs. 3,232 g/d). Calves fed TB also had greater body weight during the weaning (90.7 ± 0.97 vs. 87.9 ± 1.01 kg) and postweaning period (116.5 ± 1.47 vs. 112.1 ± 1.50 kg) compared with that of non-TB calves. The plasma metabolites and hormone concentrations were not affected by MCT or TB. These results suggest that MCT and TB supplementation in the MR may improve the growth performance and gut health of dairy calves.


Asunto(s)
Dieta , Ácidos Grasos , Animales , Bovinos , Femenino , Dieta/veterinaria , Leche , Destete , Peso Corporal , Triglicéridos , Suplementos Dietéticos , Hormonas , Alimentación Animal/análisis
3.
Science ; 375(6584): 1011-1016, 2022 03 04.
Artículo en Inglés | MEDLINE | ID: mdl-35143255

RESUMEN

The Hayabusa2 spacecraft investigated the C-type (carbonaceous) asteroid (162173) Ryugu. The mission performed two landing operations to collect samples of surface and subsurface material, the latter exposed by an artificial impact. We present images of the second touchdown site, finding that ejecta from the impact crater was present at the sample location. Surface pebbles at both landing sites show morphological variations ranging from rugged to smooth, similar to Ryugu's boulders, and shapes from quasi-spherical to flattened. The samples were returned to Earth on 6 December 2020. We describe the morphology of >5 grams of returned pebbles and sand. Their diverse color, shape, and structure are consistent with the observed materials of Ryugu; we conclude that they are a representative sample of the asteroid.

4.
Nat Commun ; 11(1): 3344, 2020 07 03.
Artículo en Inglés | MEDLINE | ID: mdl-32620751

RESUMEN

Diamond Blackfan Anemia (DBA) is a congenital bone marrow failure syndrome associated with ribosomal gene mutations that lead to ribosomal insufficiency. DBA is characterized by anemia, congenital anomalies, and cancer predisposition. Treatment for DBA is associated with significant morbidity. Here, we report the identification of Nemo-like kinase (NLK) as a potential target for DBA therapy. To identify new DBA targets, we screen for small molecules that increase erythroid expansion in mouse models of DBA. This screen identified a compound that inhibits NLK. Chemical and genetic inhibition of NLK increases erythroid expansion in mouse and human progenitors, including bone marrow cells from DBA patients. In DBA models and patient samples, aberrant NLK activation is initiated at the Megakaryocyte/Erythroid Progenitor (MEP) stage of differentiation and is not observed in non-erythroid hematopoietic lineages or healthy erythroblasts. We propose that NLK mediates aberrant erythropoiesis in DBA and is a potential target for therapy.


Asunto(s)
Anemia de Diamond-Blackfan/patología , Células Madre Hematopoyéticas/patología , Proteínas Serina-Treonina Quinasas/metabolismo , Anemia de Diamond-Blackfan/dietoterapia , Anemia de Diamond-Blackfan/genética , Animales , Benzamidas/farmacología , Benzamidas/uso terapéutico , Diferenciación Celular/efectos de los fármacos , Proliferación Celular , Células Cultivadas , Dioxoles/farmacología , Dioxoles/uso terapéutico , Modelos Animales de Enfermedad , Eritropoyesis/efectos de los fármacos , Eritropoyesis/genética , Humanos , Ratones , Ratones Transgénicos , Mutación , Cultivo Primario de Células , Inhibidores de Proteínas Quinasas/farmacología , Inhibidores de Proteínas Quinasas/uso terapéutico , Proteínas Serina-Treonina Quinasas/antagonistas & inhibidores , Proteínas Serina-Treonina Quinasas/genética , Pirazoles/farmacología , Pirazoles/uso terapéutico , Quinolinas/farmacología , Quinolinas/uso terapéutico , ARN Interferente Pequeño/metabolismo , Proteínas Ribosómicas/genética
5.
Rev Sci Instrum ; 91(2): 023321, 2020 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-32113432

RESUMEN

The Linear IFMIF (International Fusion Materials Irradiation Facility) Prototype Accelerator (LIPAc) is aiming at demonstrating the low energy section of a 40 MeV/125 mA IFMIF deuteron accelerator up to 9 MeV with a full beam current in cw operation. For such a high-power beam, the LIPAc injector is required to produce a 100 keV D+ beam with 140 mA and match it for injection into the Radio Frequency Quadrupole (RFQ) accelerator. The injector is designed by CEA-Saclay based on the high intensity light ion source (SILHI). In 2019, the commissioning of the RFQ to demonstrate the D+ beam acceleration at a low duty cycle (0.1%) was conducted. A nominal beam current of 125 mA D+ beam was accelerated up to 5 MeV through the RFQ successfully. The LIPAc injector fully satisfied the requirements for RFQ beam commissioning at the pulse mode.

6.
Scand J Surg ; 109(4): 301-308, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31354079

RESUMEN

BACKGROUND AND AIMS: T2 gallbladder cancer requires lymph node dissection for curative resection, whereas simple cholecystectomy is adequate to treat T1 gallbladder cancer. Hence, this study aimed to develop an accurate scoring system to preoperatively predict pT2 in gallbladder cancer. MATERIAL AND METHODS: We retrospectively assessed data from 57 patients with suspected gallbladder cancer who underwent curative resection between September 2003 and May 2017. Six with apparent invasion of adjacent organs on preoperative images were excluded. We evaluated preoperative computed tomography, magnetic resonance and endoscopic ultrasonographic images, blood biochemistry, and the maximum standard uptake value in fluorodeoxyglucose-positron emission tomography images. We analyzed whether correlations between preoperative findings and the depth of tumor invasion could predict pT2. RESULTS: The pathological diagnosis was gallbladder cancer in 30 (58.8%) patients, of whom 21 (69.9%) had pT2 or worse. Multivariate analyses selected carcinoembryonic antigen and tumor diameter as independent predictors of pT2 or worse (odds ratios = 1.741 and 1.098, respectively; 95% confidence intervals = 1.004-3.020 and 1.008-1.197, respectively). A regression formula was created using carcinoembryonic antigen and tumor diameter to calculate pT2 predictive scores. The area under the receiver operating characteristics curve of the pT2 predictive score was 0.873. CONCLUSION: We created a scoring system to predict pT2 in gallbladder cancer using carcinoembryonic antigen and tumor diameter. The present findings suggested that carcinoembryonic antigen is important for the preoperative evaluation of gallbladder cancer.


Asunto(s)
Adenocarcinoma/sangre , Adenocarcinoma/patología , Antígeno Carcinoembrionario/sangre , Neoplasias de la Vesícula Biliar/sangre , Neoplasias de la Vesícula Biliar/patología , Adenocarcinoma/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Colecistectomía , Femenino , Neoplasias de la Vesícula Biliar/diagnóstico por imagen , Humanos , Masculino , Persona de Mediana Edad , Invasividad Neoplásica , Estadificación de Neoplasias , Valor Predictivo de las Pruebas , Curva ROC , Estudios Retrospectivos
7.
Poult Sci ; 98(7): 2846-2857, 2019 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-30839087

RESUMEN

Stocking density (SD) of turkey toms (n = 2,868 Nicholas Select) was evaluated in 2 16-wk trials. Poults were randomly allocated to 1 of 8 independently ventilated rooms (6.71 × 10.06 m) for each trial, to reach a final target SD of 30, 40, 50, or 60 kg/m2. Air quality was monitored (carbon dioxide and ammonia) throughout the trial, and ventilation was adjusted to balance these parameters across all rooms. Within each trial, body weight and feed consumption were recorded (0, 4, 8, 12, and 16 wk of age). Body weight gain and mortality-corrected feed-to-gain ratio (F: Gm) were calculated for each 4-wk interval. Uniformity was assessed at 12 and 16 wk of age (20 birds per replicate). Mortality and culled birds were recorded daily and necropsied to determine cause of death or illness. Room temperature was recorded hourly, and litter moisture and temperature (trial 2) were evaluated weekly from 12 to 16 wk. A 1-way ANOVA was performed to evaluate the effects of SD on room temperature. Regression analyses were performed to determine the relationship between SD and all other measured variables (linear, Proc Reg; quadratic, Proc RSReg in SAS 9.4). Differences were considered significant when P ≤ 0.05. Body weight decreased as SD increased at 12 (quadratic) and 16 wk (linear). Body weight gain decreased in the last 4 wk (12 to 16, linear) and over the course of the trial (0 to 12, quadratic; 0 to 16, linear) as SD increased. Feed consumption demonstrated a linear relationship with increasing SD, increasing from week 4 to 8 and decreasing from week 12 to 16. The F: Gm ratio increased linearly with increasing SD for all time periods beginning at week 4. Flock uniformity and total percent mortality were unaffected by SD. Litter moisture demonstrated a quadratic effect and litter temperature increased (quadratic) as SD increased. Overall, increasing SD negatively impacted aspects of bird performance, including body weight, body weight gain, and feed efficiency. Feed consumption was negatively impacted later in production (week 12 to 16). Finally, overall mortality and uniformity were not affected.


Asunto(s)
Crianza de Animales Domésticos/métodos , Temperatura , Pavos/crecimiento & desarrollo , Contaminación del Aire/análisis , Amoníaco/análisis , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Peso Corporal/fisiología , Dióxido de Carbono/análisis , Conducta Alimentaria/fisiología , Masculino , Distribución Aleatoria , Pavos/fisiología , Ventilación
9.
Rev Sci Instrum ; 89(12): 123111, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30599547

RESUMEN

Herein, we report an effective method for the generation of radio-frequency (RF) sidebands in an electro-optic modulator for the simultaneous magneto-optical trapping of two isotopes. This is achieved by switching the RF signals alternately, which suppresses the generation of unwanted frequency signals and improves the laser power per sideband. The generated sidebands are successfully applied to a dual-rubidium-isotope magneto-optical trap (MOT), which results in an increased number of trapped atoms. This simple, flexible, and robust technique can be implemented in experiments that require a large number of atoms in multiple-isotope MOTs and for various applications.

10.
J Hosp Infect ; 99(1): 31-35, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-29258919

RESUMEN

BACKGROUND: Several reports have been published regarding cost increases attributable to surgical site infections (SSIs) in Europe and the USA. However, such studies have been limited in Japan. AIM: To evaluate the economic burden of colorectal SSIs on hospitals in Japan. METHODS: This study was undertaken at a Japanese university hospital. Amongst 265 patients who had undergone colorectal surgery in the Department of Coloproctological Surgery between November 2014 and March 2016, 16 patients who developed SSIs and could be allocated a diagnosis procedure combination code were selected as SSI cases. Individual SSI cases were matched to non-SSI cases based on a combination of surgical category, age band, sex, wound class, presence of stoma and risk index. Median length of stay (LOS) and piecework reference cost were compared between SSI episodes and non-SSI episodes. FINDINGS: The median LOS for patients with SSI and without SSI was 25.5 [interquartile range (IQR) 21.5-39.3] and 16.5 (IQR 12.5-18.5) days, respectively (P<0.01). The median piecework reference cost for patients with SSI and without SSI was ¥842,155 (IQR ¥716,423-1,388,968) and ¥575,795 (IQR ¥529,638-680,105), respectively (P<0.01). CONCLUSION: SSIs led to a significant increase in LOS and economic burden. Although the SSI episodes appear to be more profitable than the non-SSI episodes, the economic profit for SSI episodes was less than that for non-SSI episodes in the observation period, when opportunity costs were taken into account.


Asunto(s)
Cirugía Colorrectal/efectos adversos , Costos de Hospital , Hospitales Universitarios , Infección de la Herida Quirúrgica/economía , Infección de la Herida Quirúrgica/epidemiología , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Japón/epidemiología , Tiempo de Internación , Masculino , Persona de Mediana Edad
12.
Astron Astrophys ; 6022017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29151605

RESUMEN

AIMS: Extragalactic observations of water emission can provide valuable insights into the excitation of the interstellar medium. In particular they allow us to investigate the excitation mechanisms in obscured nuclei, i.e. whether an active galactic nucleus or a starburst dominate. METHODS: We use sub-arcsecond resolution observations to tackle the nature of the water emission in Arp 220. ALMA Band 5 science verification observations of the 183 GHz H2O 313-220 line, in conjunction with new ALMA Band 7 H2O 515-422 data at 325 GHz, and supplementary 22 GHz H2O 616 - 523 VLA observations, are used to better constrain the parameter space in the excitation modelling of the water lines. RESULTS: We detect 183 GHz H2O and 325 GHz water emission towards the two compact nuclei at the center of Arp 220, being brighter in Arp 220 West. The emission at these two frequencies is compared to previous single-dish data and does not show evidence of variability. The 183 and 325 GHz lines show similar spectra and kinematics, but the 22 GHz profile is significantly different in both nuclei due to a blend with an NH3 absorption line. CONCLUSIONS: Our findings suggest that the most likely scenario to cause the observed water emission in Arp 220 is a large number of independent masers originating from numerous star-forming regions.

13.
J Clin Pharm Ther ; 42(5): 591-597, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28503837

RESUMEN

WHAT IS KNOWN AND OBJECTIVE: Anticoagulation therapy with warfarin requires periodic monitoring of prothrombin time-international normalized ratio (PT-INR) and adequate dose adjustments based on the data to minimize the risk of bleeding and thromboembolic events. In our hospital, we have developed protocol-based pharmaceutical care, which we called protocol-based pharmacotherapy management (PBPM), for warfarin therapy. The protocol requires pharmacists to manage timing of blood sampling for measuring PT-INR and warfarin dosage determination based on an algorithm. This study evaluated the efficacy of PBPM in warfarin therapy by comparing to conventional pharmaceutical care. METHODS: From October 2013 to June 2015, a total of 134 hospitalized patients who underwent cardiovascular surgeries received post-operative warfarin therapy. The early series of patients received warfarin therapy as the conventional care (control group, n=77), whereas the latter received warfarin therapy based on the PBPM (PBPM group, n=68). These patients formed the cohort of the present study and were retrospectively analysed. RESULTS: The indications for warfarin included aortic valve replacement (n=56), mitral valve replacement (n=4), mitral valve plasty (n=22) and atrial fibrillation (n=29). There were no differences in patients' characteristics between both groups. The percentage time in therapeutic range in the first 10 days was significantly higher in the PBPM group (47.1%) than that in the control group (34.4%, P<.005). The average time to reach the steady state was significantly (P<.005) shorter in the PBPM group compared to the control group (7.3 vs 8.6 days). WHAT IS NEW AND CONCLUSION: Warfarin therapy based on our novel PBPM was clinically safe and resulted in significantly better anticoagulation control compared to conventional care.


Asunto(s)
Anticoagulantes/administración & dosificación , Procedimientos Quirúrgicos Cardíacos/métodos , Servicio de Farmacia en Hospital/organización & administración , Warfarina/administración & dosificación , Anciano , Anciano de 80 o más Años , Algoritmos , Anticoagulantes/efectos adversos , Estudios de Cohortes , Relación Dosis-Respuesta a Droga , Monitoreo de Drogas/métodos , Femenino , Hemorragia/inducido químicamente , Humanos , Relación Normalizada Internacional , Masculino , Administración del Tratamiento Farmacológico/organización & administración , Persona de Mediana Edad , Farmacéuticos/organización & administración , Tiempo de Protrombina , Estudios Retrospectivos , Tromboembolia/prevención & control , Factores de Tiempo , Warfarina/efectos adversos
14.
Sci Rep ; 6: 25700, 2016 05 10.
Artículo en Inglés | MEDLINE | ID: mdl-27161666

RESUMEN

B4C is widely used as control rods in light water reactors, such as the Fukushima Daiichi nuclear power plant, because it shows excellent neutron absorption and has a high melting point. However, B4C can melt at lower temperatures owing to eutectic interactions with stainless steel and can even evaporate by reacting with high-temperature steam under severe accident conditions. To reduce the risk of recriticality, a precise understanding of the location and chemical state of B in the melt core is necessary. Here we show that a novel soft X-ray emission spectrometer in electron probe microanalysis can help to obtain a chemical state map of B in a modeled control rod after a high-temperature steam oxidation test.

15.
Leukemia ; 30(12): 2302-2311, 2016 12.
Artículo en Inglés | MEDLINE | ID: mdl-27211267

RESUMEN

The transcription factor CREB (cAMP Response-Element Binding Protein) is overexpressed in the majority of acute myeloid leukemia (AML) patients, and this is associated with a worse prognosis. Previous work revealed that CREB overexpression augmented AML cell growth, while CREB knockdown disrupted key AML cell functions in vitro. In contrast, CREB knockdown had no effect on long-term hematopoietic stem cell activity in mouse transduction/transplantation assays. Together, these studies position CREB as a promising drug target for AML. To test this concept, a small molecule inhibitor of CREB, XX-650-23, was developed. This molecule blocks a critical interaction between CREB and its required co-activator CBP (CREB Binding Protein), leading to disruption of CREB-driven gene expression. Inhibition of CBP-CREB interaction induced apoptosis and cell-cycle arrest in AML cells, and prolonged survival in vivo in mice injected with human AML cells. XX-650-23 had little toxicity on normal human hematopoietic cells and tissues in mice. To understand the mechanism of XX-650-23, we performed RNA-seq, ChIP-seq and Cytometry Time of Flight with human AML cells. Our results demonstrate that small molecule inhibition of CBP-CREB interaction mostly affects apoptotic, cell-cycle and survival pathways, which may represent a novel approach for AML therapy.


Asunto(s)
Antineoplásicos/farmacología , Proteína de Unión a CREB/antagonistas & inhibidores , Leucemia Mieloide Aguda/tratamiento farmacológico , Animales , Apoptosis/efectos de los fármacos , Proteína de Unión a CREB/metabolismo , Puntos de Control del Ciclo Celular/efectos de los fármacos , Línea Celular Tumoral , Xenoinjertos , Humanos , Leucemia Mieloide Aguda/mortalidad , Ratones , Fragmentos de Péptidos/metabolismo , Unión Proteica/efectos de los fármacos , Sialoglicoproteínas/metabolismo , Tasa de Supervivencia
16.
Leukemia ; 30(7): 1502-9, 2016 07.
Artículo en Inglés | MEDLINE | ID: mdl-26984787

RESUMEN

Chronic myeloid leukemia (CML) is characterized by expression of Bcr-abl, a tyrosine kinase oncogene. Clinical outcomes in CML were revolutionized by development of Bcr-abl-targeted tyrosine kinase inhibitors (TKIs), but CML is not cured by these agents. CML leukemia stem cells (LSCs) are relatively TKI insensitive and persist even in remission. LSC persistence results in relapse upon TKI discontinuation, or drug resistance or blast crisis (BC) during prolonged treatment. We hypothesize that increased expression of Fas-associated phosphatase 1 (Fap1) in CML contributes to LSC persistence and BC. As Fap1 substrates include Fas and glycogen synthase kinase-3ß (Gsk3ß), increased Fap1 activity in CML is anticipated to induce Fas resistance and stabilization of ß-catenin protein. Resistance to Fas-induced apoptosis may contribute to CML LSC persistence, and ß-catenin activity increases during BC. In the current study, we directly tested the role of Fap1 in CML LSC persistence using in an in vivo murine model. In TKI-treated mice, we found that inhibiting Fap1, using a tripeptide or small molecule, prevented TKI resistance, BC and relapse after TKI discontinuation; all events observed with TKI alone. In addition, Fap1 inhibition increased Fas sensitivity and decreased ß-catenin activity in CD34(+) bone marrow cells from human subjects with CML. Therapeutic Fap1 inhibition may permit TKI discontinuation and delay in progression in CML.


Asunto(s)
Leucemia Mielógena Crónica BCR-ABL Positiva/tratamiento farmacológico , Proteína Tirosina Fosfatasa no Receptora Tipo 13/fisiología , Animales , Apoptosis/efectos de los fármacos , Crisis Blástica/etiología , Crisis Blástica/patología , Resistencia a Antineoplásicos/efectos de los fármacos , Humanos , Ratones , Células Madre Neoplásicas/patología , Dominios PDZ , Unión Proteica/efectos de los fármacos , Inhibidores de Proteínas Quinasas/administración & dosificación , Inhibidores de Proteínas Quinasas/farmacología , Inhibidores de Proteínas Quinasas/uso terapéutico , Proteína Tirosina Fosfatasa no Receptora Tipo 13/antagonistas & inhibidores , Proteína Tirosina Fosfatasa no Receptora Tipo 13/metabolismo , Recurrencia , Receptor fas/metabolismo
17.
Rev Sci Instrum ; 87(2): 02A739, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26931957

RESUMEN

The objective of linear IFMIF prototype accelerator is to demonstrate 125 mA/CW deuterium ion beam acceleration up to 9 MeV. The injector has been developed in CEA Saclay and already demonstrated 140 mA/100 keV deuterium beam [R. Gobin et al., Rev. Sci. Instrum. 85, 02A918 (2014)]. The injector was disassembled and delivered to the International Fusion Energy Research Center in Rokkasho, Japan. After reassembling the injector, commissioning has started in 2014. Up to now, 100 keV/120 mA/CW hydrogen and 100 keV/90 mA/CW deuterium ion beams have been produced stably from a 10 mm diameter extraction aperture with a low beam emittance of 0.21 π mm mrad (rms, normalized). Neutron production by D-D reaction up to 2.4 × 10(9) n/s has been observed in the deuterium operation.

18.
Rev Sci Instrum ; 87(2): 02B921, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26932093

RESUMEN

Francium is the heaviest species among the alkali elements. Due to its properties, francium is said to be of advantage in measurements of tiny observations, such as atomic parity violation and electric dipole moment. Before executing experiments with francium, it must be produced artificially because it is one of the most unstable elements. We produced francium with the nuclear fusion reaction of an oxygen beam and gold target, ionized the produced francium through a thermal ionization process, and extracted the ion with electrostatic fields. However, the thermal ionization process is known to ionize not only an objective atom but also other atomic species. Therefore, a Wien filter was installed to analyze the composition of the ion beam and purify the beam. This allowed us to improve the beam purity from ∼10(-6) to ∼10(-3).

19.
Transplant Proc ; 48(1): 271-4, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26915883

RESUMEN

PURPOSE: Sirolimus (SRL) is used to treat pulmonary lymphangioleiomyomatosis (P-LAM). There is limited evidence that SRL has systemic efficacy for the patients with extrapulmonary lymphangioleiomyomatosis (E-LAM) remaining after lung transplantation (LT) for P-LAM. This report examines the efficacy of SRL treatment for the patient with E-LAM remaining after an LT for P-LAM. CASE SUMMARY: The course of the patient's recovery from an LT for P-LAM was complicated by lymphedema in the left femoral region that was caused by two E-LAM lesions remaining in the left pelvic cavity and in the retroperitoneal area. After the LT was performed, the patient started SRL treatment to reduce the E-LAM lesions. The daily SRL dose, selected based on the standard SRL dose for P-LAM, was initiated at 1 mg/d and was maintained at 2 mg/d. The remaining E-LAM lesions and lymphedema in the left femoral region improved in approximately 9 months after the LT with the administration of both SRL and the standard immunosuppressive therapy used by Okayama University Hospital, including tacrolimus, mycophenolate mofetil, and prednisolone. The SRL and tacrolimus trough concentrations in whole blood were maintained within the therapeutic window for the next 1.5 years after initiation of SRL treatment. The patient experienced no severe adverse events that required discontinuation of the SRL treatment during this time. CONCLUSION: The patients with remaining E-LAM lesions may receive SRL treatment to improve the quality of life after LT for P-LAM as effective therapy in cases where the patient's recovery is complicated by E-LAM lesions.


Asunto(s)
Inmunosupresores/uso terapéutico , Neoplasias Pulmonares/tratamiento farmacológico , Trasplante de Pulmón , Linfangioleiomiomatosis/tratamiento farmacológico , Sirolimus/uso terapéutico , Abdomen/patología , Adulto , Femenino , Humanos , Terapia de Inmunosupresión/métodos , Neoplasias Pulmonares/patología , Linfangioleiomiomatosis/patología , Linfangioleiomiomatosis/cirugía , Linfedema/tratamiento farmacológico , Linfedema/etiología , Ácido Micofenólico/análogos & derivados , Ácido Micofenólico/uso terapéutico , Neoplasia Residual , Pelvis/patología , Prednisolona/uso terapéutico , Calidad de Vida , Tacrolimus/uso terapéutico
20.
Appl Opt ; 55(5): 1164-9, 2016 Feb 10.
Artículo en Inglés | MEDLINE | ID: mdl-26906392

RESUMEN

We demonstrate frequency offset locking between two laser sources using a waveguide-type electro-optic modulator (EOM) with 10th-order sidebands for magneto-optical trapping of Fr atoms. The frequency locking error signal was successfully obtained by performing delayed self-homodyne detection of the beat signal between the repumping frequency and the 10th-order sideband component of the trapping light. Sweeping the trapping-light and repumping-light frequencies with keeping its frequency difference of 46 GHz was confirmed over 1 GHz by monitoring the Doppler absorption profile of I2. This technique enables us to search for a resonance frequency of magneto-optical trapping of Fr.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...